| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.31 | 3e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |